![Jim Pankovich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Pankovich
Direttore/Membro del Consiglio presso Bold Therapeutics, Inc.
Posizioni attive di Jim Pankovich
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bold Therapeutics, Inc.
![]() Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | Direttore/Membro del Consiglio | - | - |
Corporate Officer/Principal | - | - |
Storia della carriera di Jim Pankovich
Statistiche
Distribuzione geografica
Canada | 2 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Bold Therapeutics, Inc.
![]() Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | Health Technology |
- Borsa valori
- Insiders
- Jim Pankovich
- Esperienza